Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Rothman Orthopaedics Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1970-01-01

Employees: 1K

Market Cap: -

Website: http://www.rothmanortho.com

Clinical Trials

Automated V Manual Impactor Study

Not Applicable

Conditions: Total Hip Arthroplasty (THA)
Impaction
Physiological Strain

First Posted Date: 2025-04-01

Last Posted Date: 2025-04-01

Lead Sponsor: Rothman Institute Orthopaedics

Target Recruit Count: 200

Registration Number: NCT06903767

Locations: 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States

Surgiphor Us in TSA

Phase 4

Conditions: Total Shoulder Arthroplasty
Shoulder Infection
Povidone Iodine

Interventions: Drug: Surgiphor
Drug: sterile saline solution
Procedure: Sample Collection

First Posted Date: 2024-09-19

Last Posted Date: 2024-09-19

Lead Sponsor: Rothman Institute Orthopaedics

Target Recruit Count: 126

Registration Number: NCT06601803

Locations: 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States

Exparel v Dexamethasone in RCR

Phase 4

Conditions: Rotator Cuff Tears
Postoperative Pain

Interventions: Drug: Liposomal bupivacaine
Drug: Bupivacaine Hcl 0.5% Inj
Drug: Dexamethasone

First Posted Date: 2024-08-28

Last Posted Date: 2024-08-28

Lead Sponsor: Rothman Institute Orthopaedics

Target Recruit Count: 126

Registration Number: NCT06575010

Locations: 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States

Wound Drain After Lumbar Fusion Surgery

Not Applicable

Conditions: Lumbar Fusion

Interventions: Other: Postoperative Drain Placement
Other: No Postoperative Drain Placement

First Posted Date: 2024-08-05

Last Posted Date: 2024-08-05

Lead Sponsor: Rothman Institute Orthopaedics

Target Recruit Count: 200

Registration Number: NCT06536842

Locations: 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States

Pain Control After Lumbar Spine Fusion

Phase 4

Conditions: Postoperative Pain
Spine Fusion
NSAID (Non-Steroidal Anti-Inflammatory Drug)

Interventions: Drug: Naproxen 500 Mg
Drug: Ketorolac
Drug: OxyCODONE 5 mg Oral Tablet
Drug: Metaxalone 800 MG

First Posted Date: 2024-07-03

Last Posted Date: 2024-07-03

Lead Sponsor: Rothman Institute Orthopaedics

Target Recruit Count: 428

Registration Number: NCT06484192

Locations: 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States

Liposomal Bupivacaine With Dexamethasone for Foot Surgery

Phase 4

Conditions: Foot Surgery
Post Operative Pain
Ankle Surgery
Popliteal Nerve Block

Interventions: Drug: Exparel 266 MG Per 20 ML Injection
Drug: Bupivacaine Hcl 0.75% Inj
Drug: Dexamethasone

First Posted Date: 2024-06-20

Last Posted Date: 2024-06-20

Lead Sponsor: Rothman Institute Orthopaedics

Target Recruit Count: 126

Registration Number: NCT06465992

Locations: 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States

Effect of Mindfulness on Pain After Total Knee Arthroplasty

Not Applicable

Conditions: Opioid Use
Total Knee Replacement
Post Operative Pain

Interventions: Other: Headspace
Procedure: Total Knee Replacement

First Posted Date: 2023-11-07

Last Posted Date: 2023-11-07

Lead Sponsor: Rothman Institute Orthopaedics

Target Recruit Count: 140

Registration Number: NCT06118073

Locations: 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States

Robotic Assisted TKA

Not Applicable

Completed

Conditions: Total Knee Replacement

Interventions: Procedure: Conventional Total knee replacement
Procedure: Total knee replacement using Omnibot Knee System
Device: Omnibot Robotic Knee System

First Posted Date: 2023-10-02

Last Posted Date: 2025-05-04

Lead Sponsor: Rothman Institute Orthopaedics

Target Recruit Count: 60

Registration Number: NCT06062615

Locations: 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States

Exparel vs Block for ACL Reconstruction

Phase 4

Conditions: Postoperative Pain
ACL

Interventions: Drug: Exparel 30 mL
Drug: 0.5% bupivacaine
Drug: Dexamethasone
Drug: iPACK block

First Posted Date: 2023-08-23

Last Posted Date: 2024-06-21

Lead Sponsor: Rothman Institute Orthopaedics

Target Recruit Count: 154

Registration Number: NCT06006624

Locations: 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States

Hip DAA Closure Techniques

Not Applicable

Conditions: Total Hip Replacement
Wound Complication

Interventions: Procedure: wound closure subcuticular running stitch using 3-0 monocryl suture without skin adhesive
Procedure: wound closure subcuticular running stitch using 3-0 monocryl suture with two layers of skin adhesive

First Posted Date: 2023-08-23

Last Posted Date: 2023-08-23

Lead Sponsor: Rothman Institute Orthopaedics

Target Recruit Count: 172

Registration Number: NCT06006572

Locations: 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy